Badania genetyczne

Clopidogrel - analysis of the cytochrome CYP2C19 activity

Clopidogrel - assessment of the P450 2C19 cytochrome activity
Test code: CYP2C19-1

Identification of CYP2C19*2, *3, *6 and *17 haplotypes.

Processing Time: Time: up to 4 weeks

Price:  660.00 zł
Dodaj do koszyka

We perform genetic testing from:

Ikona opcji  saliva (the Oragene kit, spitting into a tube is required for sample collection, therefore the kit is not suitable for children under the age of 5)
Ikona opcji  venous blood collected

Clopidogrel - analysis of the cytochrome CYP2C19 activity

Clopidogrel (Plavix) is a drug that prevents the thrombotic complications of vascular atherosclerosis. Clopidogrel is metabolised via cytochrome P450 2C19 (CYP2C19). Patients with a genetically determined low CYP2C19 activity are found to have a lower efficacy of Clopidogrel, leading to a higher incidence of cardiovascular incidents after myocardial infarction compared to patients with normal cytochrome function.